U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06809816) titled 'Efficacy of OsteoBor in Postmenopausal Osteoporosis' on Jan. 30.
Brief Summary: This study aims to evaluate the impact of boron supplementation (OsteoBor) on bone health in postmenopausal women. The trial is a phase 2, randomised, double-blind, placebo-controlled study lasting one year
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Osteoporosis, Postmenopausal
Intervention:
DRUG: Sodium pentaborate pentahydrate
Sodium pentaborate pentahydrate will be administered orally in capsule form, following the standard protocol outlined in the study design.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tabriz Unive...